Zobrazeno 1 - 5
of 5
pro vyhledávání: ''
Publikováno v:
JAMA Dermatol
Importance Topical calcineurin inhibitors (TCIs) are commonly used as second-line treatment for atopic dermatitis. In 2006, the US Food and Drug Administration issued a black box warning against TCI use, citing data from case reports and animal studi
Publikováno v:
JAMA Dermatol
IMPORTANCE: Up to 90% of patients treated with an epidermal growth factor receptor inhibitor (EGFRi) experience cutaneous toxic effects that are negatively associated with quality of life and lead to treatment interruptions. The Skin Toxicity Evaluat
Publikováno v:
JAMA Dermatology. 156:1117
Importance Certain patient groups, such as solid organ transplant recipients (SOTRs), have a significantly increased risk of developing skin cancers. The chemotherapeutic drug capecitabine has been used off label as a chemopreventive modality to supp
Autor:
Devika Gajria, Donald Chan, Azael Freites-Martinez, Shari Goldfarb, Stephen W. Dusza, Jerry Shapiro, Monica Fornier, Shanu Modi, Mario E. Lacouture
Publikováno v:
JAMA Dermatology. 154:670
IMPORTANCE: Endocrine therapy-induced alopecia (EIA) has been anecdotally reported but not systematically described. OBJECTIVE: To characterize EIA in patients with breast cancer. DESIGN, SETTING, AND PARTICIPANTS: Retrospective cohort study of 112 p
Publikováno v:
JAMA Dermatology. 152:282
Importance The risk of cancer in patients with psoriasis remains a cause of special concern due to the chronic inflammatory nature of the disease, the use of immune-suppressive treatments and UV therapies, and the increased prevalence of comorbid, we